A survey study to evaluate the nutritional status of children in community and the efficacy of â??Chaturjatadi Sambharakaâ?? on Balashosha (Protien Energy Malnutrition)

A Community Based Study to Evaluate The Efficacy of â??Chaturjatadi Sambharakaâ?? on The Nutritional Status of Children with Balashosha W.S.R. To Protein Energy Malnutrition

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027707

Enrollment

100

Registered

2020-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E44- Protein-calorie malnutrition of moderate and mild degree

Interventions

Intervention1: Chaturjatadi Sambharaka: Group B: Patients in this group will receive â??Chaturjatadi Sambharakaâ?? along with dietary counselling and nutritional rehabilitation Dose- 180mg-200mg/kg/da

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children aged 01 year to 10 years of either sex suffering from mild-to-moderate degree of malnutrition with good appetite and no major complication(criteria as specified by IAP). 2.Mother and care taker trainable to provide home based diet. 3.Parents or caretaker willing to participate in the clinical trial. 4.Not planning to leave the study area for the coming 04 months

Exclusion criteria

Exclusion criteria: 1.Children with age 10 year. 2.Children suffering from severe malnutrition (IAP criteria ) with no appetite and complications like Hypothermia , respiratory distress (presence of tachypnea ,intercostal recession),Extensive skin lesion/infection, lethargic, unconscious ,Presence of convulsions ,Severe dehydration based on history & clinical signs ,Any condition that requires an infusion or NG tube feeding and Blood haemoglobin less than 06 gm/dl. 3.Tuberculosis 4.Cerebral palsy 5.Congenital heart diseases 6.Known metabolic disorders 7.Known mal-absorption syndromes 8.Chromosomal malformations 9.Renal or hepatic disorders 10.Caretakers not willing to participate in the study

Design outcomes

Primary

Measure	Time frame
1.Gain in Weight Timepoint: 56 days	—

Secondary

Measure	Time frame
1.Serum albumin 2.A:G ratio 3.Symptomatic relief Timepoint: 56 Days	—

Countries

India

Contacts

Public ContactVedprakash Meena

National Institute of Ayurveda Jaipur

drnishaojha@gmail.com9468650449

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026